Back to Peptide Database
ImmuneResearch Phase

Alpha-MSH

Overview

Alpha-melanocyte-stimulating hormone (alpha-MSH) is a 13-amino-acid peptide derived from proopiomelanocortin (POMC). It acts via melanocortin receptors to exert potent anti-inflammatory and immunomodulatory effects, including suppression of proinflammatory cytokines and inhibition of nuclear factor kappa B (NF-kB). Therapeutic interest spans inflammatory and autoimmune disorders.

Key Research Findings

Preclinical models have demonstrated efficacy in reducing inflammation in conditions such as colitis, arthritis, and uveitis. Clinical translation has been limited, with synthetic analogs under exploration, but no large-scale trials or approvals for alpha-MSH itself have been reported.

Route of Administration

Subcutaneous injection, Intravenous

Regulatory Status

Research Phase

Interested in Alpha-MSH?

Find a verified provider experienced with Alpha-MSH protocols in your area. All providers are credentialed and use compliant sourcing.

Find a Alpha-MSH Provider

Related Peptides

Thymalin

Investigational

A peptide bioregulator originally extracted from bovine thymus gland, consisting of a mixture of polypeptides that modulate immune function. Thymalin restores T-cell mediated immunity by promoting T-lymphocyte maturation and differentiation in the thymus. It also normalizes the ratio of T-helper to T-suppressor cells and enhances phagocytic activity of neutrophils and macrophages.

LL-37

Research Phase

The only human cathelicidin antimicrobial peptide, a 37-amino acid cationic peptide cleaved from the precursor protein hCAP18. LL-37 disrupts microbial membranes through electrostatic interactions and exerts broad-spectrum activity against bacteria, fungi, and enveloped viruses. Beyond direct antimicrobial effects, it modulates innate immunity by recruiting immune cells, promoting angiogenesis, and regulating inflammatory cytokine release.

VIP (Vasoactive Intestinal Peptide)

Investigational

A 28-amino acid neuropeptide widely distributed in the central and peripheral nervous systems and immune cells. VIP acts through VPAC1 and VPAC2 receptors to produce potent anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines (TNF-alpha, IL-6, IL-12) and promoting regulatory T-cell differentiation. It also functions as a vasodilator, bronchodilator, and neuromodulator.

Thymosin Alpha 1 (Zadaxin)

Investigational

A 28-amino acid peptide originally isolated from thymic tissue (thymosin fraction 5) that serves as a potent immunomodulator. Thymosin alpha 1 enhances T-cell maturation, dendritic cell function, and antibody responses by activating Toll-like receptors (TLR2, TLR9) on innate immune cells. It promotes Th1 immune responses and augments vaccine efficacy while modulating inflammatory cytokine production.